Citation Impact
Citing Papers
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
Evaluation and Significance of Cytomegalovirus-Specific Cellular Immune Response in Lung Transplant Recipients
2011
TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON
2016
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
2018
Pathogenesis and treatment of parenteral nutrition-associated liver disease
2012
The ART Score Is Not Effective to Select Patients for Transarterial Chemoembolization Retreatment in an Italian Series
2014
Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process
2014
The MELD score in patients awaiting liver transplant: Strengths and weaknesses
2010
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Surveillance of γδ T Cells Predicts Cytomegalovirus Infection Resolution in Kidney Transplants
2015
The ART-strategy: Sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE
2013
Clinical Utility of Cytomegalovirus Cell-Mediated Immunity in Transplant Recipients With Cytomegalovirus Viremia
2011
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma
2014
State-of-the-Art Monitoring of Cytomegalovirus-Specific Cell-Mediated Immunity After Organ Transplant: A Primer for the Clinician
2012
Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients
2015
Hepatocellular carcinoma
2022 Standout
Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation
2015
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Refractory autoimmune hemolytic anemia after intestinal transplant responding to conversion from a calcineurin to mTOR inhibitor
2013
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Works of A. Dazzi being referenced
Response rate and clinical outcome of HCC after first and repeated cTACE performed “on demand”
2012
Recovery From Liver Dysfunction After Adult Isolated Intestinal Transplantation Without Liver Grafting
2006
Monitoring Cytomegalovirus T-Cell Immunity in Small Bowel/Multivisceral Transplant Recipients
2010
Model for End-Stage Liver Disease (MELD) System to Allocate and to Share Livers: Experience of Two Italian Centers
2008
Alemtuzumab Plus Cyclosporine Treatment of the Autoimmune Hemolytic Anemia in an Adult Bowel Transplant
2014